← Back

Balloon dilation vs resection: limits of the evidence

What are the limitations of current evidence comparing endoscopic balloon dilation versus surgical resection for fibrostenotic CD, regarding long-term durability and need for reintervention

ContestedNot yet clinician-reviewedlow_faithfulness

What is known

  • After EBD, repeat surgical resection is reported in 24–36% of patients at median 5–5.8 years; factors driving long-term outcome are largely unknown. 1
  • EBD durability is limited: cumulative redilatation-free 61.2% and surgery-free 72.6% at 20.5 months, with symptomatic recurrence frequent. 2,3
  • EBD immediate technical success is high (~78%) but symptomatic recurrence requiring new dilation (~41%) or surgery (~42%) is common at ~15 months. 4
  • Endoscopic strictureplasty/stricturotomy data are also immature, reintervention-free ~60–64% and surgery-free 75–90% at one year, from few small studies. 2,3

What is unknown / caveats

  • No RCT or direct head-to-head EBD vs resection comparison in the retrieved evidence
  • Outcome definitions and follow-up durations vary widely, precluding pooled durability estimates
  • Prognostic factors for long-term EBD outcome largely uncharacterized
  • Whether newer endoscopic electroincision techniques reduce reintervention versus EBD remains unresolved for lack of long-term comparative data.

References

  1. Gustavsson A, Magnuson A, Blomberg B, Andersson M, Halfvarson J, Tysk C. Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn's disease. Aliment Pharmacol Ther. 2013;37(4):430-7. PMID: 23205619.
  1. Navaneethan U, Lourdusamy D. Endoscopic Stricturotomy and Strictureplasty. Gastrointest Endosc Clin N Am. 2022;32(4):687-697. PMID: 36202510.
  1. Abreu E, Pinho R, Magro F, Estevinho MM. Efficacy and Safety of Endoscopic Strictureplasty and Stricturotomy for Crohn's Disease-Associated Strictures: A Systematic Review and Current Perspective. Diseases. 2026;14(4). PMID: 42041613.
  1. Thienpont C, Van Assche G. Endoscopic and medical management of fibrostenotic Crohn's disease. Dig Dis. 2014;32 Suppl 1:35-8. PMID: 25531351.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.


Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.

Reviewer notes

answered 2026-08-04 · corpus build 89548d50 · faithfulness 0.7419354838709677